Return
A novel Dinuclear rhenium(I) Tricarbonyl complex as a potential anticancer agent: Synthesis, structural characterisation, in vitro evaluation, density functional theory, and molecular docking binding modes
L
A
F
C
S
S
F
O
P
A
DOI:10.1016/j.jinorgbio.2026.113401.png)
Abstract
En 中文
• C1 shows selective low-micromolar anticancer activity, outperforming cisplatin. • X-ray and DFT confirm a dinuclear fac-[Re(CO)₃]+ core with a 4.11 eV HOMO–LUMO gap. • C1 targets tubulin, inducing apoptosis, autophagy, and selective DNA damage.
Keywords:
Dinuclear complex
Crystallography
DFT
Cytotoxicity
Tubulin
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.2
Papers:
7.1K
Citations:
1.2W
